MESA LABORATORIES INC /CO/ Financials
Quarterly XBRL submissions from SEC 10-K and 10-Q filings.
Income Statement (Last 8 Quarters)
(3)| Period | Revenue | YoY % | Net Income | YoY % | Operating Income | EPS |
|---|---|---|---|---|---|---|
| Q2 FY202510-Q · 2025-09-30 | $60.7M | — | $2.5M | — | $4.7M | $0.45 |
| Q1 FY202510-Q · 2025-06-30 | $841.0K | — | $4.7M | — | $3.1M | $0.85 |
| Q3 FY202510-Q · 2024-12-31 | $2.5M | — | $0 | — | $5.8M | -$0.31 |
Balance Sheet
| Period | Total Assets | Total Liabilities | Cash & Equivalents | Shareholders Equity |
|---|---|---|---|---|
| Q2 FY202510-Q | $430.4M | $251.9M | $20.4M | $178.5M |
| Q1 FY202510-Q | $435.7M | $263.2M | $21.3M | -$3.8M |
| Q3 FY202510-Q | $437.1M | $281.9M | $31.0M | -$181.0M |
Cash Flow Highlights
| Period | Operating Income | Net Income | Gross Profit | Shares Outstanding |
|---|---|---|---|---|
| Q2 FY202510-Q | $4.7M | $2.5M | $37.3M | 5,510,741 |
| Q1 FY202510-Q | $3.1M | $4.7M | $7.0M | 5,501,454 |
| Q3 FY202510-Q | $5.8M | $0 | $8.8M | 5,433,603 |
Filings
(4)Methodology
Every figure on this page is pulled directly from MESA LABORATORIES INC /CO/'s own XBRL submissions to the U.S. Securities and Exchange Commission. XBRL is the standardized tagging format the SEC requires for line items in 10-K and 10-Q filings, which means revenue, net income, and balance-sheet entries are reported by the company itself — not estimated by us.
Cayman Journal reconciles preferred GAAP tags (for example, Revenues, RevenueFromContractWithCustomerExcludingAssessedTax) and normalizes them so quarter-over-quarter comparability is preserved. Our automated ingestion runs nightly; markets editors spot-check flagged anomalies before they appear on the public hub. Where a tag is missing for a given period, we surface an em dash rather than impute a value.
Source documents are linked under Filings above and point to the original EDGAR submission index. Errors should be reported to [email protected].